INTRODUCTION
With a unique, centralized system of radiotherapy delivery, there are opportunities in Canada to implement large-scale quality improvement (QI) initiatives in radiation oncology. Such QI initiatives focus not only on the technical aspects of radiotherapy but also include the clinical aspects of patient care in oncology. Standardized collection and use of clinical patientreported outcomes (PRO) are relatively new QI initiatives for radiotherapy, with potential to benefit the care of individual patients. There is also potential to improve radiotherapy system performance through widespread PRO adoption and implementation that will benefit patients now and in the future.
ROLE OF PROS IN ROUTINE CLINICAL CARE
For decades, clinicians have used clinical assessments to determine how individual patients respond to specific treatments, specifically how a patient is functioning, whether their symptoms are lessening or worsening and generally how well treatment has worked. Until recently, little attention has been given to collecting outcomes directly from patients themselves. To complement physician assessment of clinical outcomes, PROs are designed to capture patients' perspectives on care, focusing on the impact treatment has not only on physical but also psychological well-being and quality of life.
1 Beyond patient symptom management during treatment, PROs play a critical role in oncology survivorship, improving continued communication between provider and patient, 2 quality of life, 3 and even patient survival. 4 
EXAMPLES OF PRO INITIATIVES IN CANADIAN RADIOTHERAPY PROGRAMS
A few individual Canadian cancer programs and research teams have made considerable advances in how PRO data can be captured and utilized to improve individualized patient care. To date, many of these PRO initiatives have been focused on high-level quality of life measures at the local and provincial levels. For example, the Edmonton Symptom Assessment System (ESAS) is a generic measure, which assesses the severity of nine symptoms. It is routinely used across the cancer system in Ontario as part of a program embedded within the provincial cancer agency, Cancer Care Ontario (CCO). 5, 6 Researchers in Ontario have taken advantage of this wide-scale data collection to describe symptom burden in the cancer population, showing unmet need in symptom management for those undergoing curative intent treatment 7 to those receiving end-of-life care. 8 Provincial level PRO research has also shown an association between symptom burden and health service use, with studies demonstrating effectiveness of routine PRO documentation through outcome of decreased emergency department visits. 9 In the province of British Columbia (BC), the BC Cancer Agency has developed a PRO collection system that is now embedded into clinical practice and used extensively by frontline care providers within radiotherapy departments, including radiation oncologists, radiation therapists, nurses, and counselors. 10 A focus of the PRO collection platform was electronic storage of data that could then be used for research, knowledge translation, and ultimately a meaningful change in point of care practice. Numerous clinical applications have been demonstrated. With over 40,000 patients accrued since its inception in 2013, PROs have been used to confirm in a realworld population-based setting of British Columbia that single fraction radiotherapy is as effective as multiple fraction radiotherapy in improving pain, function, and well-being for patients treated for bone metastases. 11, 12 These data, combined with audit data of prescribing practices and a knowledge translation strategy, led to increased use of single fraction radiotherapy across all six British Columbia cancer centers, saving money, increasing quality of life, and reducing wait times. 13, 14 Not all provinces have mandated implementation of PRO measures and not all Canadian radiation oncology programs have the experience with PROs to know how best to use the information collected. As the majority of PRO work has been center-specific, there is an important need to look nationally at how best to improve alignment among these local level activities. With radiotherapy administered across 44 regional cancer treatment facilities known as radiation oncology programs, Canada's centralized system of radiotherapy delivery may be a key feature to the success of pan-Canadian QI initiatives such as PRO implementation. Given that the benefits of PROs are multidimensional, it is perhaps not surprising that routine evaluation of patient outcomes has been recognized as an indicator of radiation oncology program quality by professional bodies such as the Canadian Partnership for Quality Radiotherapy (CPQR). 15 
CPQR: LEADING PAN-CANADIAN RADIOTHERAPY QI INITIATIVES
CPQR is a unique partnership of Canadian radiotherapy professional organizations (Canadian Association of Radiation Oncology-CARO, Canadian Organization of Medical Physicists-COMP, and the Canadian Association of Medical Radiation Technologists-CAMRT). Since its inception in 2010, the CPQR has established itself as a national leader in radiotherapy safety and QI initiatives, working to develop programs and tools that drive systems performance improvements at the local, national, and international levels. 16 To date, CPQR work has included the creation of a pan-Canadian radiotherapy online incident reporting system, 17,18 along with guidance documents for technical quality control 19 and patient engagement. 20, 21 A major goal of the CPQR initiatives is self-sustainability, evidenced by the recent creation of Accreditation Canada radiotherapy standards, derived from the previously developed CPQR radiation oncology program key quality indicators (KQI).
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The Canadian radiotherapy community has seen benefit from CPQR's iterative approach to QI initiatives 23 such as expansion of radiotherapy peer review, another KQI now embedded within the Accreditation Canada standards. A recent CPQR-endorsed survey of Canadian radiation oncology programs reported substantial variation in the extent, timing, and documentation of radiotherapy peer review despite its perceived importance and establishment as standard of care. 24 Since then, in collaboration with CPQR, a National Peer Review Project has been undertaken to assist radiation oncology programs in meeting their goal of KQI compliance with peer review.
PRO USE: A KEY QUALITY INDICATOR OF RADIOTHERAPY PROGRAMS
Interestingly, in CPQR's recent pan-Canadian survey of KQI compliance, the two KQIs related to patient outcome reporting were considered by radiation treatment programs across Canada as being among the most challenging to achieve in a consistent manner. The new Accreditation Canada standards went one step further beyond inclusion of CPQR's KQI (Table I) , to expect not only radiation oncology program review of toxicity and disease control outcomes but also use of PROs (Table II) . As it has facilitated pan-Canadian expansion of KQI such as peer review, CPQR now aims to support radiation oncology centers striving to meet the accreditation requirement of PRO program implementation. Not surprisingly, following input from the broader radiotherapy community, CPQR has identified increased use of PROs in routine clinical care as a priority for CPQR's third mandate over the next 5 yr. (Table I : CPQR key quality indicators related to PRO) 15 ( 
CPQR'S FUTURE MANDATE: PROMOTING A PAN-CANADIAN APPROACH TO PRO USE
CPQR's PRO program will take a multipronged approach to building an adaptable, scalable system for radiotherapy PROs that aims to improve national alignment and uptake ( Fig. 1: CPQR's multilevel approach to building a pan-Canadian system for PRO).
While developing a pan-Canadian approach, there is potential to capitalize on existing PRO programs such as the one developed in British Columbia, existing radiation oncology program infrastructure and the expertise now siloed within the radiotherapy and general cancer control communities. A key objective of the pan-Canadian CPQR model is real-time improvement in the care of individual patients using electronic user interface to capture PRO data and translate it directly to the care team during treatment visits. Geographically distributed, early adopter programs across Canada will participate in a pilot project of collecting and utilizing PROs to improve individual patient-centered care during and following the curative and palliative treatments. Point-of-care RT PROs will be piloted in the palliative radiotherapy setting and for one curative tumor site initially. Using its established model of community engagement, CPQR will develop PRO guidelines that both foster a shared understanding of the challenges associated with local PRO use, together with a reasonable expectation of the infrastructure and operating costs associated with successful implementation. In addition, CPQR will also evaluate the feasibility of collecting, utilizing, and sharing radiation treatment PROs on a pan-Canadian level, integrating improvements in the care of individual patients locally while driving higher level improvements in pan-Canadian health system performance. At present time, it is unclear as to which, if any, PRO measures Canadian radiation oncology programs are using. A CPQR-led pan-Canadian survey of the 44 radiation oncology programs will be the first step in identifying which PRO measures are currently being used and how. With this information at hand, and guidance from PRO content experts, it is hoped that CPQR may be able to provide future guidance to radiation oncology programs with a shortlist of appropriate or relevant disease specific and general PRO measures. 25 
LINKING PROS WITH RADIOTHERAPY PLAN PARAMETERS
From a system perspective, using standardized community-endorsed measures can further improve radiotherapy quality through harmonized care and improvements to the care process. As an example, CPQR's previous mandate saw the implementation of a national online radiotherapy incident reporting system, which included a standardized taxonomy developed by experts through a Delphi process and piloted in local radiation oncology programs across Canada. 17 ,18 CPQR will capitalize on its previous successes at involving radiotherapy program staff and other allied health professionals in the development and local integration of its PRO programs, to establish pan-Canadian alignment to support improved quality, system performance, and population-based learning. The noted differences in local use and uptake of PRO measures limit the ability of any pan-Canadian system to aggregate and analyze data. To be successful, early work will involve the development of a minimum dataset (MDS) of clinical, dosimetric, and PRO data elements to be recorded for all patients within the identified pilot disease sites. Standardized collection of clinical and radiotherapy plan information will be crucial to interpret PROs in the context of the patient journey before, during, and after treatment. Timing is fortuitous, with an AAPM Task Force soon to release a guideline for standardized radiotherapy nomenclature (TG263), 26 as CPQR hopes to involve early adopter programs in developing guidelines for standardizing the collection and sharing of radiation treatment plan information. This will greatly amplify the system-level learning opportunities compared to having only radiation treatment information or PROs alone.
COMMUNITY ENGAGEMENT: A KEY TO SUCCESS FACTOR IN CPQR'S PAN-CANADIAN QI INITIATIVES
When attempting to make system-level change, the involvement of frontline care providers cannot be overlooked. The CPQR PRO model will incorporate local champions to help ensure seamless adaptability of standardized pan-Canadian models into local systems and processes. The CPQR infrastructure already includes representatives from each of the 44 radiation treatment centers across Canada, known as the National Quality Advisory Committee (NQAC). Each radiation oncology program's NQAC representative acts as a communication conduit between CPQR and the radiotherapy programs to ensure that CPQR initiatives are being integrated into program priorities and that frontline recommendation for improvement is heard by CPQR leadership. Finally, it is acknowledged that strong patient engagement has been a key success to realizing CPQR QI initiatives. The development of the CPQR PRO model will be no different, ensuring patients are active participants in the planning and implementation stages.
CONCLUSION
Point-of-care radiotherapy PROs with real-time feedback to practitioners will bring immediate value to patients. The process will engage patients and their care providers. It is proposed that beyond this immediate, front line benefit, standardized implementation of PRO collection and use will have a system-wide benefit, improving the quality of radiotherapy delivery across radiation oncology programs. Standardized collection of PRO data across Canada will also empower research looking at correlations between different radiation doses and techniques and patients report of their side effects on a national scale. The centralized health care system and unique collaborative culture within CPQR make Canada a prime candidate to take a leader and collaborator role in international endeavors to promote expansion of PRO collection and use in radiotherapy.
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